Honasa Consumer Reports 22.5% Revenue Growth in Q2 FY26, EBITDA at ₹48 Cr; Mamaearth Back in Green
Honasa Consumer reported 22.5% revenue growth and ₹48 Cr EBITDA in Q2 FY26. Mamaearth is back in green, and The Derma Co. reached ₹750 Cr ARR. New brands Luminéve and Fang launched.
The announcement covers comprehensive financial results for the quarter, including significant revenue growth, profitability, and strategic initiatives like new brand launches and market share gains. These factors are highly material to the company's valuation and future prospects.
The company reported strong revenue growth, stable EBITDA, and positive PAT. Key brands like Mamaearth and The Derma Co. showed significant achievements and growth. The launch of new prestige brands and expansion into new segments indicate a positive strategic outlook.
* Honasa Consumer Ltd. announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. * Q2 FY26 revenue from operations on a like-for-like (LFL) basis stood at ₹566 crore, marking a 22.5% year-on-year (YoY) increase. * The company reported a strong EBITDA of ₹48 crore (8.4%) and a Profit After Tax (PAT) of ₹39 crore for Q2 FY26. * Gross profit stood at 71.9%, indicating healthy top-line growth and improving margins. * Volume growth (UVG) in Q2 remained strong at 16.7%, showcasing resilience and volume-led growth in the core business. * Mamaearth's growth is back in green, with NielsenIQ data showing continued share gains for Mamaearth face cleansers (+123 bps). The Rice Facewash entered the ₹100 crore ARR club. * The Derma Co. was recognized as India’s No. 1 sunscreen brand by Euromonitor (CY’24) and crossed the ₹750 crore ARR milestone. * Younger brands grew over 20% YoY in Q2, maintaining momentum across focus categories. * General Trade distribution deepened with a 35%+ YoY increase in direct outlets billed in H1 FY26. * Innovation continues to be a key driver, with The Derma Co. enhancing its Vitamin C Serum and Aqualogica introducing India’s first in-vivo tested Anti-Pollution Sunscreen. * Honasa expanded into premium skincare with Luminéve, launched exclusively on Nykaa, and invested in Fang, a prestige oral care brand focused on teeth whitening. * Varun Alagh, Chairman, CEO & Co-founder, stated that Q2 marked steady growth, reflecting the strength of their growth playbook and category-first strategy. He emphasized continued focus on scaling Honasa as a House of Purposeful Brands.
What to do with a filing like this
Honasa Consumer Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Honasa Consumer Limited. Read the original for the full detail.